ArticleMolecular therapy oncolytics2022

Feasibility study of a novel preparation strategy for anti-CD7 CAR-T cells with a recombinant anti-CD7 blocking antibody.

Jing Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.